Gigamune, Inc.

Biotechnology company · San Francisco, California, United States

Gigamune, Inc. is a biotechnology company headquartered in San Francisco, California, United States. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2025.

www.gigamune.comProfile compiled from public records. Is this your company? Request a correction or update

Gigamune at a glance

Typebiotechnology company

HeadquartersSan Francisco, California, United States

Employees (self-reported, 2025)3

What does Gigamune do?

US government research funding

8 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2018 to 2025). NIH funding came from the National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Frequently asked questions about Gigamune

Where is Gigamune headquartered?

Gigamune, Inc. is headquartered in San Francisco, California, United States.

What does Gigamune do?

Gigamune, Inc. is a biotechnology company.

Similar companies

Ossium Health, Inc.San Francisco, California, United States
Vir Biotechnology, Inc.San Francisco, California, United States
Titan Pharmaceuticals IncSan Francisco, California, United States
Senti Biosciences, Inc.San Francisco, California, United States
Amygdala Neurosciences IncSan Francisco, California, United States
Excision BioTherapeutics IncSan Francisco, California, United States
ProLynx, Inc.San Francisco, California, United States
Second Genome, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences